We’re Moving Your Greatest Idea Forward
Have an invention? Tell us about it! Please note that public disclosures such as conference abstracts and publications may preclude our ability to protect your invention. Be sure to inform OTC of any imminent or prior disclosures!
Through our partnerships with faculty, industry, entrepreneurs and investors, ensure that Duke innovations reach the marketplace for the benefit of society and to enable future investment in Duke research and innovation.
Duke will be a leader in transferring its knowledge and innovations to the worldwide community.
Faculty & Innovators
We work together to augment the impact of your innovations, build connections with industrial, entrepreneurial, legal and investment resources and amplify the value and impact of your Duke innovations.
Industry & Partners
Partner with us to bring transformational ideas to the marketplace.
Let us help you think through the opportunity, craft a business plan, and connect with the management, mentors, and investors to make your venture a success!
Duke Capital Partners
The investment network of Duke alumni, faculty, and parents which provides its members with exciting opportunities to invest in early-stage companies with a Duke connection – and for Duke-affiliated entrepreneurs to pitch their companies for potential investment.
Learn more about translational funding resources and opportunities that aim to accelerate the path from research to commercialization.
Looking for cutting-edge technology? We welcome you to browse our list of available technologies from therapeutics to imaging and software and find one that will make a difference!
Bringing your innovation to the market requires a lot of resources. We are here to guide you on available resources at Duke and beyond that will help you realize your dream.
Duke Start-up: Warden Bio
Warden Bio is developing novel AAV-mediated gene therapies for glycogen storage disorders (GSDs). The GSD gene therapy is based on research led by the lab of Dr. Priya Kishnani, Chen Family Distinguished Professor & Division Chief for Medical Genetics at Duke University, in close collaboration with Dr. Aravind Asokan, Professor & Director of Gene Therapy at Duke University and Co-Founder of StrideBio. Over the past three decades, Dr. Kishnani has built an interdisciplinary team with world-leading GSD expertise whose efforts are most notably demonstrated by the long-standing research and clinical experience that resulted in FDA approval of alglucosidase alfa (Myozyme/Lumizyme) as the...
Kishnani Priya, Aravind Asokan, Sun Baodong
Duke Start-up: Solar Unsoiled
Solar Unsoiled is an interactive, data-driven platform to optimize global solar energy production. The company is maximizing solar energy profit and reducing financial risk using predictive models to mitigate the impact of energy losses due to dust and air pollution. Solar Unsoiled targets optimization surrounding the issue of detrimental soiling losses.
Duke Start-up: Basking Biosciences Inc.
Basking Bio, founded by endovascular neurosurgeon and research scientist, Shai Nimjee, is developing a drug-antidote pair for treatment of patients with ischemic stroke using technologies founded out of Duke Professor of Surgery, Bruce Sullenger’s Cardiovascular Biology Lab. Basking Biosciences is developing the only reversible anti-thrombotic therapeutic to treat ischemic stroke. Founded based on IP licensed from Duke and Ohio State Universities, DTRI-031, Basking’s lead compound, leverages the proven aptamer technology platform developed in founder Bruce Sullenger’s lab at Duke to create a highly specific inhibitor of Von Willebrand Factor (VWF) and a paired reversal agent. This paired therapy enables rapid...
Bruce Sullenger , Shai Nimjee
Isolere Bio: Inside the journey of a Duke biotech start-up
From an invention in 1999, to start-up creation in 2017, to acquisition in 2023, learn of the twists and turns of Duke start-up Isolere Bio…
Read More about Isolere Bio: Inside the journey of a Duke biotech start-up
Four Points Innovation Funds Research Collaboration Between Duke University and The University of Manchester
This investment aims to accelerate research to develop a novel therapy to treat a genetic condition called Alport syndrome.
Read More about Four Points Innovation Funds Research Collaboration Between Duke University and The University of Manchester
FDA approves elacestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
Radius Health, with its eventual partner Stemline Therapeutics/Menarini Group, licensed the cancer indications for this drug in 2017 out of the lab of Dr. Donald…
Read More about FDA approves elacestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
The NIOSH Respiratory Fit Evaluation Challenge
To compete in Phase 1 of the Challenge, participants must submit a 10-page (maximum) concept paper that outlines an idea on how to improve respirator fit testing and feedback by May 1, 2023.
Entrepreneurship Workshop Series: Workshop for Medical Device Designers
The workshop will review the guiding principles behind the medical regulatory framework to develop an appreciation of the foundational logic and philosophy behind medical device regulation.
Entrepreneurship Workshop Series: Fundamentals of Startup Law
Learn about the legal issues founders face when launching a company.
From Scientific Breakthrough to Real-World Impact: Steps to Success in Regenerative Medicine and Advanced Biomanufacturing
This single-day workshop will walk participants through the essential steps to success in the burgeoning field of regenerative medicine and advanced biomanufacturing.
Medical, Biomedical & Biodefense: Support to the Warfighter Symposium
The symposium will foster awareness and dialogue among government (DoD), academia, and industry stakeholders in support of our warfighters.
NCBiotech Aligning Health Care Innovation in North Carolina: Health Systems, Payers, Innovators, and the Quintuple Aim
This event provides the health care, life sciences, and innovation community with an enhanced understanding of the strategic priorities and technology innovation areas of interest to health systems and payers.
SBIR/STTR R&D Funding Overview and Grant Accounting / Legal Considerations
Join the NC SBTDC for a detailed overview of the SBIR / STTR federal R&D funding mechanisms for small businesses, grant accounting practices, and legal considerations.
Entrepreneurship Workshop Series: Intellectual Property (IP) For Innovators
You are invited to attend the upcoming session of Duke EngEn's Entrepreneurship Workshop Series: Intellectual Property (IP) For Innovators with Greg Carlin, J.D.
Overview of Schrödinger Small-Molecule and Biologics Tools for Duke and UNC
Pizza, networking, and discussion over Schrodinger's small-molecule and biologics drug discovery technologies.